MedPath

Comparison of Efficacy of Dexmedetomidine V/S Fentanyl as an Adjuvant to 0.5%Ropivacaine in Ultrasound-Guided Supraclavicular Brachial Plexus Block in Upper Limb Surgery

Not yet recruiting
Conditions
Fracture of shaft of radius,
Registration Number
CTRI/2020/07/026913
Lead Sponsor
Department of anaesthesia SMS medical college JLN marg Jaipur rajasthan
Brief Summary

In our study we are comparing efficacy of dexmedetomidine and fentanyl as an adjuvant to 0.5% ropivacaine in usg guided supraclavicular block in upper limb surgeries.To find out onset and  duration of sensory and motor block. Comparison of duration of post operative analgesia.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients undergoing elective surgical procedure on upper limb of duration 1-4 hours Patients willing to give written and informed consent Patients belonging to ASA class-I and II.

Exclusion Criteria

Uncooperative patients Local pathology at the injection site Disability limiting the performance of block History of convulsion, severe neurological deficit Allergy to the drug used Bleeding disorders, coagulopathies Patients with history of respiratory,cardiac,hepatic and renal disease Chronic use of opioid or any other analgesics.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
For significance in difference in mean variable i.e., outcome variables 1-5 --- Student unpaired T test of significance24 hrs
Secondary Outcome Measures
NameTimeMethod
For significance in difference in median VAS score i.e., outcome variable 6 --- Mann Whitney TestFor significance in difference in proportion of cases with complications i.e., outcome variable 7 --- Chi square test of significance

Trial Locations

Locations (1)

SMS medical college jaipur

🇮🇳

Jaipur, RAJASTHAN, India

SMS medical college jaipur
🇮🇳Jaipur, RAJASTHAN, India
Dr Poonam kalra
Principal investigator
9413416787
poonamkalra24@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.